browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
bc4afd0b-88db-43a6-b064-79dc21e5859d
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 15:37:55
Income (reported)
$30,000
Expenses (reported)
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

CAPITOL COUNSEL LLC

Government affairs.

Contact
TRACEY A. GRAY
Phone
+1 202-861-3200
Address
zip:20005, city:Washington, state:DC, street:700 13th Street NW, 2nd Floor
Client

AMERICAN ACADEMY OF OPHTHALMOLOGY

State
CA
Country
US
Government-entity client
false
Effective date
2009-11-01
Issues lobbied + lobbyists (4)

MMM — Medicare/Medicaid

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.